Synthetic biology is becoming a factory stack

What if biology could be built like a factory? Synthetic biology designs biological parts, networks, pathways, and whole organisms to do useful work, and it is already moving into commercial products^[1][2].

That factory model spans medicines, materials, foods, fuels, sensors, and climate products: cheaper drugs, biomaterials, plant-based foods, biofuels, biosensors, and greener manufacturing are all in scope^[3][4][5].

The DBTL loop is the accelerator: design, build, test, learn. Standardized parts, automation, biofoundries, and even cell-free systems make the cycle more systematic, faster, and less like ad hoc trial and error^[6][7][8].

Automation and AI push throughput. Robots can run many experiments in parallel, ML can pick the next designs, and models get better when data are standardized and consistent. Small datasets and scale-up still limit the gains^{[9][10][11][12]}.